tiprankstipranks
Trending News
More News >
Avalo Therapeutics, Inc. (AVTX)
:AVTX
US Market

Avalo Therapeutics (AVTX) Balance Sheet

Compare
1,028 Followers

Avalo Therapeutics Balance Sheet

Avalo Therapeutics's total assets for Q3 2025 were $125.10M, a decrease of -1.17% from the previous quarter. AVTX total liabilities were $33.55M for the fiscal quarter, a 52.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 150.73M$ 20.99M$ 33.37M$ 80.21M$ 43.76M
Total Liabilities
$ 17.70M$ 13.69M$ 44.28M$ 57.13M$ 19.19M
Total Equity Gross Minority
$ 133.03M$ 7.30M$ -10.91M$ 23.08M$ 24.56M
Other Metrics
Currency in USD

Avalo Therapeutics Debt to Assets